Talis Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Monomermonomerbio.cominJan 2024 · $5.6M
Monomer Bio builds software and automation solutions for biological research and development, serving research labs and biotech companies.
AI & Machine LearningBiotechData & InfrastructureDeep TechSaaS
Jimmy(CEO & Co-founder)Mark(Co-founder & Advisor)Yang(CTO)
Co-investorsLifeX Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.